American Heart Association (AHA) Scientific Sessions 2022
Nov 5 - Nov 7, 2022
Title: ARO-ANG3, an Investigational RNAi Therapeutic, Decreases Serum Angiopoietin-Like Protein 3, Triglycerides, and Cholesterol in Patients With Mixed Dyslipidemia
Date/Time: November 7, 2022, 3:00 p.m. CST
Presenter: Robert S. Rosenson
Session: The Present and Future of Lipid Lowering
Title: ARO-APOC3, an Investigational RNAi Therapeutic, Decreases Serum Apolipoprotein C3, Triglyceride, and Non-HDL-C Concentrations While Increasing HDL-C in Patients With Severe Hypertriglyceridemia
Date/Time: November 7, 2022, 3:08 p.m. CST
Presenter: Christie M. Ballantyne
Session: The Present and Future of Lipid Lowering